OTC : JANL
-$8 (-13.79%)
OTC
Darren Seirer
Integrated Freight & Logistics
Industrials
JANL
353
US
USD
0.85
0.79
0.74
0.26
0.93
$207.44M
0.25
2.18
1.31
38.05
$4.17
$5.41M
2.49%
3.52%
23.20%
3.08%
10.85
0.09
0.09
3/5
0 Analysts
%
1.45
7/9
-$27.75M
$192M
$158.76M
$9.47M
$48.64M
0.21
3.92
0.79
23.20%
9.12%
9.96%
76.07%
$50.70
-124 days
| Name | Title |
|---|---|
| Brendan J. Killackey | Chief Information Officer |
| Darren Seirer | Chairman, Chief Executive Officer & President |
| John Joseph Gonzalez | Senior Advisor for Mergers & Acquisitions and Independent Director |
| Nathan Shandy | Chief Financial Officer, Principal Accounting Officer, Treasurer & Secretary |
No votes yet today — be the first to share your view!
About Janel Corporation (OTC:JANL) Stock
Headquartered in New York, NY, Janel Corporation was founded in 1974 and provides a range of services worldwide through its various subsidiaries. The firm adopted its current name in April 2015, previously known as Janel World Trade Ltd. Janel operates across three core business segments: Logistics, Manufacturing, and Life Sciences. The Logistics segment specializes in global cargo movement and supply chain management. This encompasses freight forwarding across air, ocean, and ground modalities, alongside customs brokerage, warehousing, distribution, and supplementary services such as customs filing, cargo insurance procurement, strategic logistics planning, product repackaging, and real-time shipment tracking. Within the Manufacturing division, the company develops and distributes mixing ... apparatus and equipment catering to diverse industries, including chemicals, inks, paints, construction, plastics, adhesives, cosmetics, food, and pharmaceuticals. Lastly, the Life Sciences segment is dedicated to the production and supply of monoclonal and polyclonal antibodies, diagnostic reagents, and other immunologic reagents crucial for biomedical research. This segment further supports academic and industrial research scientists through antibody manufacturing, and produces items for other life science enterprises on an original equipment manufacturer (OEM) basis.
Frequently Asked Questions
What is the current Janel Corporation (JANL) stock price?
Janel Corporation(OTC:JANL) stock price is $50 in the last trading session. During the trading session, JANL stock reached the peak price of $58 while $21 was the lowest point it dropped to. The percentage change in JANL stock occurred in the recent session was --13.79% while the dollar amount for the price change in JANL stock was -$8.
JANL's industry and sector of operation?
The OTC listed JANL is part of Integrated Freight & Logistics industry that operates in the broader Industrials sector.
Who are the executives of JANL?
Brendan J. Killackey
| Chief Information Officer
Darren Seirer
| Chairman, Chief Executive Officer & President
John Joseph Gonzalez
| Senior Advisor for Mergers & Acquisitions and Independent Director
Nathan Shandy
| Chief Financial Officer, Principal Accounting Officer, Treasurer & Secretary
|
How many employees does JANL have?
Number of JANL employees currently stands at 353. JANL operates from 80 Eighth Avenue, New York City, NY 10011, US.
Link for JANL official website?
Official Website of JANL is: https://www.janelcorp.com
How do I contact JANL?
JANL could be contacted at phone #212 373 5895 and can also be accessed through its website. JANL operates from 80 Eighth Avenue, New York City, NY 10011, US.
How many shares of JANL are traded daily?
The average number of JANL shares traded daily for last 3 months was 111.
What is the market cap of JANL currently?
The market value of JANL currently stands at $59.32M with its latest stock price at $50